All posts by imreal

Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials, Upcoming Webinar Hosted by Xtalks


An understanding of integrated approaches toward expanding this population in clinical trials will ultimately benefit not only both patients and Sponsors alike, but also will have a positive global impact on disease burden while also continuing to evolve the thinking on chronically ill populations.

21st century medicine and technology has seen exciting advancements at a pace and scale so remarkable that it exceeds the medical trajectory as compared to all of human history combined. This evolution, marked by preventative measures in healthcare, has improved the longevity and quality of life for patients, which also equates to a rising incidence and prevalence of chronic disease, especially chronic kidney disease (CKD).

Indeed, chronic kidney disease is now the 10th leading cause of mortality compared to the early 1990’s when it was over the 35th leading cause, with projections over time placing it much higher on the ranking in the future. Historically, however, those with chronic kidney disease have represented a population traditionally excluded from clinical trials, especially those in cardiovascular disease despite the improved understanding of its implications related to comorbid diseases.

Despite the inherent complexities of chronic kidney disease, with its intricate bidirectional cardiovascular effect, along with being one of the strongest risk factors for cardiovascular death, there has never been a more important time to include those with chronic kidney disease in clinical trials, especially those related to cardiovascular disease. An understanding of integrated approaches toward expanding this population in clinical trials will ultimately benefit not only both patients and Sponsors alike, but also will have a positive global impact on disease burden while also continuing to evolve the thinking on chronically ill populations.

Join this webinar to learn about integrated approaches to include patients with chronic kidney disease in cardiovascular clinical trials, benefiting both patients and improving disease burden worldwide.

Join experts from Medpace, Dr. Ajay Srivastava, MD, FASN, Sr. Vice-President, Medical Department; Dr. Nicholas Alp, MD, PhD, FACC, Sr. Vice-President, Medical Department; and Heather Lohr, Sr. Director, Clinical Trial Management, for the live webinar on Thursday, June 22, 2023, at 11am EDT (4pm BST/UK).

For more information, or to register for this event, visit Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

GOLO, the Health and Wellness Solutions Company, Increases Support for Community Initiatives with Donations to Three Organizations


GOLO supports community-based organizations.

GOLO increases support for community-based organizations.

“Our donations to One Warm Coat, Wounded Warriors Family Support, and Alex’s Lemonade Stand Foundation further reinforce our commitment to organizations that positively impact our communities,” says Jennifer Brooks, Co-founder and President of GOLO.

As part of its ongoing commitment to support community-based initiatives, GOLO recently donated $60,000 across three national organizations: One Warm Coat, Alex’s Lemonade Stand Foundation, and Wounded Warriors Family Support. The funding will focus on various initiatives, including coat drives for children and families, support programs for children with cancer, and veterans’ services.

“Our donations to One Warm Coat, Wounded Warriors Family Support, and Alex’s Lemonade Stand Foundation further reinforce our commitment to organizations that positively impact our communities,” says Jennifer Brooks, Co-founder and President of GOLO.

Donation beneficiaries:

One Warm Coat –

One Warm Coat’s mission is to provide free coats to children and adults in need while promoting volunteerism and environmental sustainability. Over the past 30 years, One Warm Coat has facilitated more than 43,000 coat drives, collecting 7.3 million coats that have been distributed through 1,400 nonprofit partners across all 50 states.

“One Warm Coat is grateful for this generous contribution from GOLO, which will help provide warmth to thousands of children and adults this year while promoting volunteerism and environmental sustainability,” says Beth W. Amodio, President and CEO of One Warm Coat. “More than 37 million Americans are living at or below the poverty level, and these individuals and families need and deserve shelter from the elements and the knowledge that someone cares.”

Alex’s Lemonade Stand Foundation –

Alex’s Lemonade Stand Foundation (ALSF) shares the vision of their founder and creator, Alexandra “Alex” Scott — a cure for all children with cancer. Their mission is to change the lives of children with cancer through funding impactful research, raising awareness, supporting families, and empowering everyone to help cure childhood cancer.

“We are grateful to GOLO for joining us in the fight against childhood cancer,” says Liz Scott, Alex’s mom and Co-Executive Director at Alex’s Lemonade Stand Foundation. “Their support allows us to continue our mission to fund critical research as well as to provide support to families looking for a cure.”

Wounded Warriors Family Support –

Wounded Warriors Family Support is an independent nonprofit organization whose mission is to provide support to the families of those who have been wounded, injured, or killed during combat operations.

“Through our partnership, GOLO has made significant contributions towards improving the quality of life for veterans and their families,” says Kate McCauley, CEO and President of Wounded Warriors Family Support.

About GOLO

GOLO empowers individuals and communities by helping them take control of their health and wellness. Click here to learn more about our charitable giving initiatives.

GOLO® products provide safe solutions to weight-loss and wellness while helping individuals transition to a healthier and sustainable lifestyle. GOLO has reached over three million people worldwide who now have a chance at healthy, sustainable, and affordable weight loss. For more information about the GOLO for Life® plan, visit golo.com or call 800-730-4656.

# # #

Share article on social media or email:

Prevent Blindness Launches Multiple Efforts to Provide Education and Resources on the Effects of Vision Loss and Blindness on Mental Health


Prevent Blindness offers new resources to raise awareness and provide education for patients, care partners and healthcare service professionals, on mental wellness and vision loss.

“As a patient advocacy organization, we’ve heard for many years from our constituents that one of the biggest challenges of vision loss is how deeply it impacts mental health,”- Julie Grutzmacher, director of patient advocacy and population health initiatives at Prevent Blindness.

Because individuals with vision loss can experience a higher prevalence of depression, anxiety and other mental health issues as compared to their sighted peers, Prevent Blindness, the nation’s leading nonprofit eye health and safety organization, has engaged experts from around the country to raise awareness, provide education and offer newly developed resources for patients, care partners and healthcare service professionals.

The second day of the upcoming 2023 Prevent Blindness Focus on Eye Health Summit, July 13, will be dedicated to presentations and forums addressing mental health and vision. Keynote speaker Julian Eaton, BSc, MSc, MBBS, MRCPsych, Mental Health Director, CBM Global, Assistant Professor, London School of Hygiene and Tropical Medicine, will kick off the day with his presentation, “Innovative Mental Health Approaches,” followed by discussions on “The Public Health Connection Between Mental Wellness and Vision” and “Policy Opportunities and Obstacles Around Vision and Mental Wellness.” Registration for the summit is now available and free to all attendees.

According to a recent study from the Centers for Disease Control and Prevention (CDC), one in four adults with vision loss reported anxiety or depression. Younger adults with vision loss had almost five times the risk of serious anxiety or depression compared to adults 65 and older.

“As a patient advocacy organization, we’ve heard for many years from our constituents that one of the biggest challenges of vision loss is how deeply it impacts mental health,” said Julie Grutzmacher, director of patient advocacy and population health initiatives at Prevent Blindness. “Working together with patients, their families and healthcare professionals, we are targeting specific areas for improvement and creating strategies to bring support for those whose mental health is significantly affected from vision impairments.”    

Prevent Blindness recently convened an all-volunteer Mental Health Task Force, consisting of professionals from a variety of fields, including ophthalmology, optometry, social work and clinical psychology, as well as patients experiencing vision loss. The group created the Vision Loss and Mental Health: Key Takeaways from an Interprofessional Task Force issue brief, and collectively identified opportunities to promote process improvement and advocacy in:

  • vision rehabilitation,
  • resource development and dissemination,
  • training for providers (eye care, primary care and mental health),
  • developing an integrated eye care model.

The issue brief is intended for policy makers, providers, professionals and program personnel. Funding support for the promotion and dissemination of the mental health issue brief has been provided by Horizon Therapeutics.

As a next step, Prevent Blindness is working with the Task Force to develop training modules geared towards mental health providers.

A new episode in the Prevent Blindness Focus on Eye Health Expert Series, “Vision Impairment and Mental Wellness” is now available. Dr. Connie Hills, psychologist, consultant and speaker, shares her experience of vision loss from age-related macular degeneration (AMD), and her recommendations on how professionals and patients should work together to improve mental health outcomes. Dr. Hills also discusses her participation in the Prevent Blindness ASPECT Patient Engagement Program. The program is designed to empower individuals to be engaged in their eye health.

Through the free Living Well with Low Vision resource, Prevent Blindness offers the “Vision Loss and Mental Wellness” webpage. The site provides detailed steps to support mental health, and a listing of mental health services from a variety of organizations.

For free information on general eye health, please visit PreventBlindness.org. For a patient guide, low vision resource directories and the latest news on low vision rehabilitation, research and developments in the treatment of eye disease, and a wide range of other topics, visit LowVision.PreventBlindness.org.

About Prevent Blindness

Founded in 1908, Prevent Blindness is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, visit us at PreventBlindness.org, and follow us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

Share article on social media or email:

David Ensignia Tennis Academy and DETA Pickleball Club announce free court time, clinics for tennis and pickleball players


David Ensignia Tennis Academy and DETA Pickleball Club team up with Break the Love.

David Ensignia Tennis Academy and DETA Pickleball Club team up with Break the Love.

We’re excited to expand our programming to meet the needs of active adults and to make our pickleball courts available to everyone at no cost thanks to Break the Love and Walmart.

Tennis and pickleball players 55+ can now reserve pickleball courts and take advantage of tennis clinics offered by David Ensignia Tennis Academy and its affiliate, the DETA Pickleball Club, at no cost during certain weekday hours from June through September.

And to ensure no one feels left out, David Ensignia Tennis Academy and DETA Pickleball Club have teamed up with Walmart to provide free access to tennis and pickleball courts during certain hours every day of the week. Via Break the Love, an organization that makes racquet sports accessible (whether through courts, classes or clinics), players can reserve courts at Break the Love at no cost by simply showing a Walmart receipt.

“There’s no better time than now to start playing tennis or pickleball,” said Jacit Gonzalez, business development manager for David Ensignia Tennis Academy and DETA Pickleball Club. “For active adults over 55, we’ve devised special open play times and clinics so they don’t have to fight for court time.”

David Ensignia Tennis Academy operates tennis courts at the Miccosukee Golf & Country Club in Kendall (eight courts), Continental Park in Kendall (eight courts), Coral Pine Park in Pinecrest (five courts) and Archimedean Academy (five courts). The tennis academy offers private and group lessons with Professional Tennis Registry-certified coaches. It also hosts local, regional and international tournaments and family events. Courts cost up to $10 to reserve depending on the location and time of day.

Pickleball, the nation’s fastest-growing sport, is booming in Miami-Dade County. But the limited number of courts, combined with confusing schedules at public parks, keep many from picking up a paddle. Dedicated players hop from park to park in search of a match. Busy open-play sessions often mean spending more time on the bench than in the game.

At DETA Pickleball Club at Miccosukee Golf & Country Club, the public has access to 16 dedicated pickleball courts, the most at any one location in Miami-Dade County. It’s also one of only three locations in the tri-county area with 16 or more courts. The club, which doesn’t require a membership or registration fee, offers round robins, ladders, tournaments and clinics. DETA also offers a DUPR rating program for pickleball players. Courts cost up to $10 to reserve.

“We offer a lot of options for players at different skill levels, including great events where they can play for fun, to improve their rating or compete for prizes,” said Stephane Jolicoeur, lead pro and director of DETA Pickleball Club. “We’re excited to expand our programming to meet the needs of active adults and to make our pickleball courts available to everyone at no cost thanks to Break the Love and Walmart.”

55+ Pickleball

What: Free Pickleball Open Play (Beginner and Intermediate)

When: Tuesday–Thursday, 8:00 a.m.–11:00 a.m. (June–September)

Location: DETA Pickleball Club at Miccosukee Golf and Country Club, 6401 Kendale Lakes Dr., Miami, FL 33183

Reserve: detapickleballclub.com

55+ Tennis

What: Tennis clinic – Beginners only

When: Wednesdays, 8:00 a.m. (June–September)

Location: David Ensignia Tennis Academy at Continental Tennis Center, Continental Park, 10000 SW 82nd Ave., Miami, FL 33156

Reserve: davidensigniatennis.com

Break the Love with Walmart

Pickleball

What: Free court time*

When: Monday–Friday, 8:00 a.m.–3:00 p.m.

             Saturday and Sunday, Noon–6 p.m.

Location: DETA Pickleball Club at Miccosukee Golf and Country Club, 6401 Kendale Lakes Dr., Miami, FL 33183

*Reserve at BreaktheLove.com (must submit a Walmart receipt)

Tennis

What: Free court time*

When: Monday–Friday, 8 a.m.–3:00 p.m.

Location: David Ensignia Tennis Academy at Miccosukee Golf & Country Club, 6401 Kendale Lakes Dr., Miami, FL 33183

*Reserve at BreaktheLove.com (must submit a Walmart receipt)

The Miccosukee Golf and Country Club is open to the public. There are no membership fees. Book a court at David Engisnia Tennis Academy or DETA Pickleball Club or download the Court Reserve App to reserve.

                                                         ###

About David Ensignia Tennis Academy

Tennis pro David Ensignia founded David Ensignia Tennis Academy in 1990, launching personalized tennis instruction, clinics, camps and tournaments for players of all ages. Programs are run by top professional players, trainers and sports psychologists. The academy operates out of Miccosukee Golf & Country Club in Kendall, Coral Pine Park in Pinecrest, Continental Park and Archimedean Academy in south Miami-Dade County. David Ensignia Tennis Academy operates courts that are approved by the International Federation of Tennis. It’s programs are UTR and ITF rated. Visit davidensigniatennis.com.

About DETA Pickleball Club

Founded by David Ensignia Tennis Academy in 2023, DETA Pickleball Club opened at Miccosukee Golf & Country Club offering lessons, clinics and tournaments on its 16 dedicated pickleball courts, the most in Miami-Dade County. The club offers official DUPR rating and all pros are Professional Pickleball Rating certified. Visit detapickleballclub.com.

Share article on social media or email:

Onymos Expands Features-as-a-Service Platform to IoT Development


Onymos

Onymos

“Our IoT solution provides engineering teams and developers with the necessary building blocks to create the ecosystem required for the devices and systems to function properly.” – Shiva Nathan, Founder & CEO, Onymos

Onymos, developer of the world’s first Features-as-a-Service platform, today announced they are extending their platform to support the creation of Internet of Things (IoT) and Internet of Medical Things (IoMT) ecosystems and applications. Immediately available, enterprises can access the IoT capabilities through the Onymos Features-as-a-Service platform.

According to McKinsey, IoT is estimated to enable $5.5 trillion to $12.6 trillion in value for enterprises by 2023. With Onymos, enterprises can realize the value of this technology by arming their engineering teams with the foundation for their IoT and IoMT ecosystems. This foundation includes local storage, security, and user applications for device administration and customer insights.

Additionally, Onymos IoT provides engineering teams with:


  • Onymos Edge: A protocol-agnostic gateway that enables IoT devices and apps to communicate.
  • Onymos Access: A drop-in log-in solution that is delivered as a front-end code library, which can be connected to a customer’s user database. This library contains the most popular OAuth 2.0-powered providers like Okta, Auth0, Azure AD and social auth providers like Apple, Google, and Facebook, among others, allowing enterprises to choose their preferred authentication method.
  • Onymos DataStore: A set of utility functions for securely storing and retrieving data in the cloud. It standardizes access and connectivity to all of the most popular cloud providers like AWS, Azure, and Google Cloud Platform (GCP).

“IoT is growing more and more popular each day, and many industries like healthcare, agriculture, and energy are beginning to deploy the technology as part of their operations. However, for enterprises to benefit from the technology, they must first assemble the underlying ecosystem that enables the devices to connect and exchange data with other devices and systems — an activity that is extremely complex and arduous,” said Shiva Nathan, Founder and CEO of Onymos. “Our IoT solution provides engineering teams and developers with the necessary building blocks to create the ecosystem required for the devices and systems to function properly.”

As also reported by McKinsey, production environments — such as those in manufacturing and hospitals — and human-health settings will be the key areas in which the benefits of IoT can be seen the most. Enterprises in these areas and beyond have enlisted the help of Onymos to build IoT and IoMT ecosystems 80% faster than standard development timelines.

The Onymos Features-as-a-Service platform is a pro-code platform that enables companies in various industries — including retail, healthcare, delivery, digital media, and entertainment — to achieve unmatched speed, quality, and value in their application development and innovation. It has over 20 foundational app features, including access, biometrics, chat, deep links, location, notifications, and payments. These features can be easily added to new or existing applications and include the UI/UX, security, help with compliance requirements, underlying logic that runs on the device, the server-side functions and integrations that process and store data in the cloud, and automatic updates. The Onymos platform also supports many of the most popular frameworks for web and mobile application development, messaging protocols, and more.

For more information on Onymos or its IoT capabilities, please visit onymos.com.

About Onymos

Onymos is the developer of the world’s first Features-as-a-Service platform. Our more than 20 full-stack Onymos Features enable enterprises to build innovative and differentiated apps with unmatched speed, quality, and value. Onymos is trusted by top brands, including Albertsons, CVS, and Walmart.

For more information, visit onymos.com, and join the conversation on Twitter and LinkedIn.

Share article on social media or email:



PredxBio Strengthens Leadership Team with Appointment of Brad Spitz as Chief Commercial Officer


This is an incredibly exciting moment for me as I join the remarkable team at PredxBio and become an integral part of their mission. I am thrilled to have the opportunity to bring this game-changing Spatial Biology technology to the market in a truly transformational way.

PredxBio, the leading company in Spatial Biology and Explainable AI for predicting the progression of disease, has announced the appointment of Brad Spitz, MBA, as its Chief Commercial Officer. In this role, Brad will drive the company’s commercial growth strategy, lead global sales and business development efforts, and further expand PredxBio’s presence in the biopharma industry.

Dusty Majumdar, PhD, CEO of PredxBio, stated, “With Brad’s extensive expertise in driving commercial excellence and his proven track record of executing strategies at scale, he is the perfect candidate to lead our global commercial team in the upcoming phase of growth. His leadership will be instrumental in taking our proprietary Explainable AI-powered Spatial Biology analytics solutions to new heights of adoption in the biopharma industry. Having successfully grown businesses for renowned life science and biopharma companies over the past two decades, Brad brings invaluable experience to our team and his appointment as Chief Commercial Officer positions the company for accelerated growth, forging impactful partnerships, and furthering the adoption of innovative solutions in spatial biology and cutting-edge analytics!”

Brad Spitz is a highly accomplished and versatile executive in the life sciences industry, with a wealth of experience across various sectors including biotech, pharmaceuticals, molecular diagnostics, academia, digital pathology, AI, and oncology healthcare. His impressive career includes a 19-year tenure at Johnson & Johnson, where he held roles in multiple operating companies such as Ethicon, Ortho-Clinical Diagnostics, Veridex, and Janssen Diagnostics. During his time at Johnson & Johnson, Brad played a pivotal role in pioneering CellSearch©, one of the earliest liquid biopsy tests in oncology designed to measure circulating tumor cells. Brad has also held Vice President of Sales positions at esteemed companies such as ANGLE Plc., Orbis Biosciences (Acquired by Adare Pharma Solutions), and Congenica, showcasing his expertise in driving sales growth and building successful commercial strategies. In addition to his industry experience, Brad has been involved with the prestigious Mayo Clinic as part of the BioPharma Dx team and most recently served at PaigeAI. Brad holds an MBA from Elon University and a bachelor’s degree with double majors in Economics and Communications from the University of Wisconsin, Madison.

“This is an incredibly exciting moment for me as I join the remarkable team at PredxBio and become an integral part of their mission. I am thrilled to have the opportunity to bring this game-changing Spatial Biology technology to the market in a truly transformational way,” said Brad Spitz. “Integrity, resiliency, and building great relationships will be at the core of my efforts to help grow this company. I am deeply passionate about leading the fight against cancer, and I cannot wait to collaborate with our key stakeholders at PredxBio and our BioPharma partners to leverage the power of spatial biology in delivering innovative therapies that will positively impact the lives of patients. I am honored to be a part of this journey and look forward to bringing our pioneering solutions to the market as we unlock the true power of spatial biology.”

The PredxBio platform seamlessly integrates multimodal data, such as spatial proteomics, spatial transcriptomics, and brightfield pathology, to uncover the hidden circuitries of tumor microenvironments and reveal the complex network biology of cancer. By performing highly scalable, Explainable AI (xAI) powered spatial analyses of diverse imaging techniques, PredxBio generates actionable insights for biomarker discovery, identifying drug targets, and designing effective clinical trials. Through the quantification of cell-cell interactions, identification of intermediate cell types and states, and discovery of microdomains, PredxBio delves into the organizing principles of spatial intratumor heterogeneity, providing a mechanistic understanding of tumor initiation, progression, and response to therapy. This comprehensive platform drives personalized therapeutic options, improving prediction accuracies based on spatial tumor biology and enabling optimal treatment selection for individual patients. With the launch of the PredxBio brand, we establish our leadership position in Spatial Biology, uniquely capable of predicting patient outcomes with 90%+ accuracy by unraveling the hidden biological circuitries of cancer.

About PredxBio

PredxBio is a Pittsburgh, PA-based company focused on the development of explainable AI-powered spatial analytics software platforms to decipher the complex cancer biology and bend the survival curve for immunotherapy cancer patients. PredxBio’s solutions empower clinicians/researchers to accelerate drug discovery, optimize clinical trials, advance companion diagnostics, personalize therapeutic options, and improve clinical workflows. PredxBio has already completed engagements with early paying customers including pharma partners who are harnessing PredxBio’s solutions to assess treatment response in immunotherapy.

http://www.predxbio.com

Share article on social media or email:

Reproductive Specialists of the Carolinas Welcomes Accomplished Fertility Doctor And Innovator To Practice


Reproductive Specialists of the Carolinas (RSC), a leading fertility practice, is proud to announce that Dr. Ashley Eskew, an award-winning, renowned reproductive endocrinologist and infertility specialist, recently joined this boutique fertility practice as their third doctor. She complements her diverse medical experience with a unique clinical background. Dr. Eskew continues to provide RSC patients with a high level of advanced and inclusive reproductive care.

Double board-certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility by the American Board of Obstetrics and Gynecology, Dr. Eskew has the education and training needed to diagnose and treat all infertility causes.

Dr. Eskew received her undergraduate degree from Furman University in Greenville, South Carolina. Next, she received her Medical Doctorate from the University of Louisville in Kentucky. Completing her residency training in Obstetrics and Gynecology at Atrium Health in Charlotte, North Carolina, she served as Chief Resident. Dr. Eskew completed her fellowship training in Reproductive Endocrinology and Infertility at Washington University in St. Louis, where she also earned her Master of Science in Clinical Investigation (MSCI).

Dr. Eskew’s clinical interests focus on the impact of dietary and lifestyle factors on fertility and reproductive outcomes, particularly those for in vitro fertilization (IVF) procedures. Her devotion to this area extends to her role as co-founder of OvulifeMD, an evidence-based digital education company that helps empower individuals undergoing fertility treatment to make lifestyle changes that actually matter.

Among the many awards she’s received are the Pacific Coast Reproductive Society’s “Excellence in Training Award- Oral Abstract” and “Merit Excellence in Fellowship Research,” and the Washington University Institute of Clinical and Translational Sciences (ICTS) Just-In-Time Funding Award. Dr. Eskew writes and publishes a host of peer-reviewed articles and studies advancing reproductive medicine and optimizing patient experiences. Additionally, she lectures and presents at various fertility organizations.

As a long-time advocate of improving access to fertility services and reproductive health for all patients, particularly in Charlotte, where access to fertility care is challenging and limited, she brings her passion for patient care, diverse experience, and interests to the RSC practice.

“Becoming a part of an innovative practice like Reproductive Specialists of the Carolinas, and working alongside Drs. Johnson, Ghidei, and the RSC team, is very exciting,” stated Dr. Eskew. “Having the opportunity to improve access to state-of-the-art fertility care in the Carolinas, while helping patients achieve their dreams of a family is incredibly rewarding. I look forward to helping make those dreams come true at RSC’s new state of the ART IVF facility.” In her downtime, she practices yoga, travels, and enjoys time outdoors, while spending quality time with friends and family.

“I am very happy that Dr. Eskew is joining our practice. As with Dr. Ghidei, another recent addition, I feel that our patients will benefit from working with a new, young, intelligent, and passionate REI,” stated Dr. Johnson. “Beyond her diverse experience and skill, I am excited to see how her specific research background, with its focus on dietary and lifestyle impacts, enhances our fertility care. Welcome to the RSC family, Dr. Eskew!”

Dr. Eskew’s addition to the RSC staff is just this practice’s latest announcement. In 2022, the practice brought on Dr. Luwan Ghidei, who, like Dr. Eskew, is an award-winning reproductive endocrinologist and infertility specialist, providing patients with greater care and treatment opportunities. In addition, the practice relocated to a new, 11,000-square-foot facility in Charlotte, North Carolina. Boasting a cutting-edge IVF laboratory, this location provides patients with such treatment options as IVF, intrauterine insemination (IUI), infertility assessments, oncofertility, and egg freezing. This new location complements the practice’s boutique-style approach, as patients won’t have to travel far for their retrieval, making their fertility care experience more convenient and accessible.

Reproductive Specialists of the Carolinas is located at 1918 Randolph Rd, Ste 410, Charlotte, NC 28207-1109. To learn more, please email info@fertilitycarolinas.com or call to schedule an appointment to see Dr. Eskew, at (704) 247-2209.

Share article on social media or email:

MedReview to present “Best Practices in Leveraging Clinical Validation for Payment Integrity” at AHIP 2023


News Image

As we see in this success story, applying a payment integrity solution like MedReview’s does not merely stabilize a health plan’s revenue–it can make the difference between a plan failing or thriving.

Lorenzo Jackson, Sales Account Director at MedReview, Inc. – a leading provider of payment integrity, utilization management and quality surveillance services – will present “Best Practices in Leveraging Clinical Validation for Payment Integrity” at AHIP 2023 in Portland, Oregon. The presentation will be held on Tuesday, June 13, at 6:35 PT.

Deploying successful clinical validation is a challenging–yet critical–endeavor for health insurance providers. In this session, learn how a plan with 10K members went from insolvency to an average savings of $60.41 per member per year by following MedReview’s best practices, such as honing in on outliers and applying MedReview’s algorithm to select claims to review. Learn about best practices in DRG clinical validation and how to benchmark the outcomes of a successful payment integrity program.

“As we see in this success story, applying a payment integrity solution like MedReview’s does not merely stabilize a health plan’s revenue–it can make the difference between a plan failing or thriving,” Jackson said.

Lorenzo Jackson is an experienced payment integrity professional with nearly 20 years of expertise in the healthcare industry. Throughout his career, Jackson has been dedicated to helping healthcare organizations optimize revenue by identifying and mitigating payment errors and reducing wasteful activity. As a Sales Account Director for MedReview, he is responsible for helping health plans drive revenue growth by building and maintaining strong relationships, understanding needs, and delivering innovative solutions that address unique challenges.

Presentation: Best Practices in Leveraging Clinical Validation for Payment Integrity

Date/Time: Tuesday, June 13, 2023 | 6:35 PM PT

Location: Presentation Theater #1: Booth 1137 (Halls C-D, Level 1)

Presenter: Lorenzo Jackson, MBA, MHSA, Sales Account Director, MedReview Inc.

MedReview offers healthcare payers innovative, physician-led payment integrity solutions to help fight healthcare fraud, waste and abuse. The company’s clinically driven approach to DRG claim review has resulted in a total of $351 million in savings back to payer clients last year.

About MedReview

Headquartered in the financial district of New York City and serving all U.S. states and territories, MedReview has been a leading provider of payment integrity, utilization management and quality surveillance services for more than 40 years. A physician-led organization with a passion for ensuring that health care claims fairly represent the care provided, MedReview provides timely independent hospital billing audits and clinical validation reviews on behalf of health plans, government agencies and Taft-Hartley organizations, saving millions of dollars for its clients each year.

Share article on social media or email:

Fertility Source Companies™ Celebrates 20th Anniversary Milestone


Fertility Source Companies (“FSC”), among the country’s largest egg donation and surrogacy agencies operating on a national level, is celebrating two momentous achievements. For 20 years, they’ve been providing the most comprehensive third-party reproductive care and coordination to individuals and couples in the United States and from around the world. Concurrently, FSC is also honoring the birth of its 700th baby born via surrogacy. Both events spotlight the agency’s success in ensuring the highest degree of commitment, support, and guidance to intended parents, egg donors, and surrogates.

Celebrating A Generation of Family-Building

Since opening in 2003, FSC has helped many couples and individuals — over 4,500 national and international intended parents (IPs), including those within the LGBTQ+ community — to achieve their goals of beginning or growing their families.“

As Fertility Source Companies celebrates 20 years in a deeply competitive industry, it is with great awe that I find myself a part of this amazing community,” said Donna Raidy, current CEO. “When I started as a Case Manager in egg donation cases, I found myself thinking of all the possibilities for these families we were honored to help create.” She continues, “I felt compelled to do it ‘right,’ to put into place a system that honored not only the IPs we were working with, but also the resulting children from these donations.”

A Growing Number of Successful Surrogacies

As they reach two decades of family-building success, FSC is also excited to be celebrating a second milestone — the births of over 700 babies via The Surrogacy Source. This specialized surrogacy program quickly and carefully matches IPs with gestational surrogates. Prospective parents are assured of a safe connection with a surrogate, one who has been fully screened through a background check, insurance review, and psychological evaluation.

“As we celebrate the last two decades and hit the wonderful milestone of 700 babies born through our surrogacy division, I am excited for the next steps Fertility Source Companies will take and all of the families we will have a part in building,” stated Raidy. “We thank everyone who has entrusted us with their amazing journey.”

These historic achievements are due to the efforts and dedication of all FSC team members over the years, including physicians, nurses, embryologists, technicians, and administrators. Their board, formerly run by Steve Masler, and now led by Raidy, are founding members of the Society for Ethics in Egg Donation and Surrogacy (SEEDS). They have created a blueprint on how to succeed and have longevity in an industry that sees many ups and downs. They look forward to many more years of helping people realize their parenthood goals.

About Fertility Source Companies

With egg donor and surrogate locations in 35 states, Fertility Source Companies is headquartered at 25909 Pala #180, Mission Viejo, CA 92691. For more information, please call to schedule an appointment at (877) 375-8888, or internationally, at (949) 872-2800. You can also fill out our form to submit any questions or concerns, and we’ll quickly respond.

Share article on social media or email:

COSMEDIX Announces Their Newest Launch of Zinc Defense Mineral Sunscreen Broad Spectrum SPF 50 with Age-Defying Ingredients Just in Time for Summer


“In general we are favoring formulations that are mineral, safe, and still elegant!” says board certified, New York Based dermatologist Dr. Hadley King. “I prefer mineral SPF ingredients like Zinc Oxide.”

Luxury skincare brand COSMEDIX has announced their latest launch of the hydrating Zinc Defense Mineral Sunscreen Broad Spectrum SPF 50. This is the newest sun protection product from the brand and features a weightless formula that helps to condition and protect skin while leaving behind a naturally radiant-looking finish.

This Mineral Sunscreen Broad Spectrum SPF 50 helps to replenish moisture loss while shielding and protecting the skin from UVA and UVB rays which can damage the complexion and lead to early signs of aging. The milky, serum-like formula instantly blends to a smooth, glowy-looking finish and can double as a primer under makeup or can be worn alone for a healthy-looking appearance.

Zinc Defense is formulated with age-defying Clove and Goldenrod Extract, Ectoin, and Zinc Oxide. Clove and Goldenrod Extracts help to reduce the appearance of redness, fine lines, and wrinkles for a more youthful-looking appearance, while Ectoin aids in maintaining hydration to help protect skin from environmental stressors, such as pollution. Zinc Defense features 23% Zinc Oxide, which is a sunscreen ingredient that helps protect skin from UVA and UVB rays for a healthier-looking complexion.

“We know that exposure to the sun’s UV rays is an important factor when it comes to aging of the skin, not to mention skin cancer. In general we are favoring formulations that are mineral, safe, and still elegant!” says board certified, New York Based dermatologist Dr. Hadley King. “I prefer mineral SPF ingredients like Zinc Oxide to chemical sunscreens because they offer broad spectrum protection, and there are fewer concerns about safety for ourselves and our environment.”

To apply Zinc Defense, shake well and gently dispense a couple of drops of sunscreen into the palm of the hand. Warm product in hands before smoothing into skin for a weightless glow. Smooth in thoroughly before moving on to the next area. A little bit of Zinc Defense goes a long way! Apply 15 minutes before sun exposure. Use a water-resistant sunscreen if swimming or sweating and reapply at least every 2 hours.

Zinc Defense pairs well with other products in the COSMEDIX clinical skincare lineup to create the ultimate daily routine. As always, Zinc Defense is 100% cruelty-free and is designed to work with all skin types. Zinc Defense Mineral Sunscreen Broad Spectrum SPF 50 will be available to purchase on cosmedix.com beginning June 5th.

About COSMEDIX

Since our inception in 1999, we’ve been driven by one guiding principle: the desire to deliver gentle, effective, and cruelty-free skincare solutions for all. Our skincare products are designed to work with all skin tones and skin types, not against them. Whether your skincare concern is dark under eye circles, hyperpigmentation, acne, redness, sensitive skin, fine lines and wrinkles or dehydration—our luxurious line of skincare delivers real results without harsh side effects. COSMEDIX skincare can be found in spas across the world with professional aesthetician treatments and can be purchased both at spas and on our website. As pioneers in clean skincare, we’ve always prioritized the use of the purest ingredients for the skin. We’re also 100% cruelty-free—no exception.

Share article on social media or email: